Skip to content
healthcare.dev

Dalfampridine

NDC 62756-429, Dalfampridine, tablet, extended release, from Sun Pharmaceutical Industries, Inc..

Product NDC
62756-429
Status
Listed
Labeler
Sun Pharmaceutical Industries, Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208292
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62756-429 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DALFAMPRIDINE10 mg/1

Pharmacologic classes

Potassium Channel Antagonists [MoA]; Potassium Channel Blocker [EPC]

Package NDCNDC-11Package
62756-429-866275604298660 TABLET, EXTENDED RELEASE in 1 BOTTLE (62756-429-86)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d61e15fa-0334-49a0-ab41-c9a36b726b57

Use it

Look up 62756-429 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62756-429 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62756-429. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.